Invesco’s Juno Therapeutics, Inc. JUNO Stock Holding History

Invesco’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-169,809	Closed	-$7.76M	–	3826
2017 Q4	$7.76M	Buy	169,809 +123,374	+266%	+$6.15M	﹤0.01%	1725
2017 Q3	$2.08M	Sell	46,435 -6,559	-12%	-$224K	﹤0.01%	2544
2017 Q2	$1.58M	Sell	52,994 -352	-0.7%	-$8.69K	﹤0.01%	2740
2017 Q1	$1.18M	Buy	53,346 +34,846	+188%	+$747K	﹤0.01%	2950
2016 Q4	$349K	Buy	18,500 +9,120	+97%	+$223K	﹤0.01%	3417
2016 Q3	$281K	Buy	9,380 +2,158	+30%	+$67.1K	﹤0.01%	3451
2016 Q2	$278K	Sell	7,222 -7,144	-50%	-$297K	﹤0.01%	3437
2016 Q1	$547K	Buy	14,366 +4,489	+45%	+$156K	﹤0.01%	3216
2015 Q4	$434K	Sell	9,877 -1,958	-17%	-$97.1K	﹤0.01%	3313
2015 Q3	$482K	Buy	11,835 +964	+9%	+$42.3K	﹤0.01%	3261
2015 Q2	$580K	Buy	10,871 +7,667	+239%	+$407K	﹤0.01%	3323
2015 Q1	$194K	Sell	3,204 -146,796	-98%	-$7.12M	﹤0.01%	3697
2014 Q4	$7.83M	Buy	+150,000	New	+$6.71M	﹤0.01%	1638

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Invesco's JUNO Position: Q1 2018 in Review

Invesco sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 169,809 shares — an estimated $7.76M sold.

Invesco first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $7.83M in Q4 2014. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Invesco reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Invesco sold 169,809 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $7.76M.
Invesco first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
Invesco's Juno Therapeutics, Inc. position peaked at $7.83M in Q4 2014.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Invesco's 13F filing for Q1 2018, filed 15 May 2018.